Skip to main content
  • Report an Adverse Event
  • Locate an MSL
RNAiScience logo
Search Menu
  • Home
  • Alnylam & RNAi
  • Congresses & Publications
  • Therapeutic Areas
  • Our Therapies
  • Pipeline & Clinical Trials
  • Connect With Us
  • Payer Connect
  • Log in
  • Sign Up
Alnylam logo
  • Privacy Policy
  • |
  • Terms of Use
| © 2025 Alnylam

This site is intended for US healthcare professionals.
© 2025 Alnylam Pharmaceuticals, Inc. All rights reserved.
MED-US-ALL-2400001

RNAiScience logo
  • Home
  • Alnylam & RNAi
  • Congresses & Publications
  • Therapeutic Areas
  • Our Therapies
  • Pipeline & Clinical Trials
  • Connect With Us
  • Payer Connect
Alnylam logo
  • Privacy Policy
  • |
  • Terms of Use

More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.

  • Report an Adverse Event
  • Locate an MSL
  • Log in
|
  • Sign Up

Breadcrumb

  • Alnylam Congresses & Publications >
  • Heart Failure Association (HFA) 2025
  • < Alnylam Congresses & Publications

Heart Failure Association (HFA) 2025

May 17-20, 2025 | Belgrade, Serbia

 

The material below is to support scientific exchange. Any content about investigational therapeutics or investigational uses of FDA-approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval. 

Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.


Vutrisiran reduces all-cause mortality, cardiovascular mortality, and cardiovascular events in patients with transthyretin amyloid cardiomyopathy: Analysis from the HELIOS-B trial

Bookmark this pageBookmark this page

Presentation

Link to published manuscript at the Journal of the American College of Cardiology

Clinical Presentation and Treatment Landscape of Patients with Transthyretin Amyloidosis With Cardiomyopathy: A Real-world Study in Five European Countries and Japan

Bookmark this pageBookmark this page

Poster

Utility of Genetic Testing For Diagnosing hATTR Patients: Results from a European and Middle East Genetic Testing Program

Bookmark this pageBookmark this page

Poster

TRITON-CM: A Phase 3 Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Bookmark this pageBookmark this page

Poster

Vutrisiran In Patients With Transthyretin Amyloidosis with Cardiomyopathy In HELIOS-B Who Had Progressed On Tafamidis

Bookmark this pageBookmark this page

Presentation

This site is intended for US healthcare professionals.
© 2025 Alnylam Pharmaceuticals, Inc. All rights reserved.
MED-US-ALL-2400001

  • Privacy Policy
  • |
  • Terms of Use
| © 2025 Alnylam
Alnylam logo
RNAI Logo

You are now leaving this site and being directed to a third-party website that is not maintained by Alnylam. Alnylam does not endorse and is not responsible for content or maintenance of third-party websites.

ContinueCancel

RNAI Logo

You are now leaving this site and being directed to another Alnylam website.

ContinueCancel

RNAI Logo

Intended for US healthcare professionals. This site is intended to provide balanced, evidence-based information to support scientific exchange. It is not intended to provide medical advice or recommendations for clinical practice.

Information about investigational therapeutics or investigational uses of approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval.

Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.

Are you a healthcare professional practicing in the United States?

I confirm I am a US healthcare professional

I am a US payer or healthcare decision maker

I am not a US healthcare professional, or a US payer or healthcare decision maker

I am an Alnylam Team Member

X
Don't miss out!

Sign in to bookmark information and create your personal library

Log in

Don't have an account? Sign up